Pluri (PLUR) Non-Current Assets (2011 - 2025)

Pluri (PLUR) reported Non-Current Assets of $16.8 million for Q4 2025, up 97.76% year-over-year from $8.5 million in Q4 2024, and little changed quarter-over-quarter from $16.8 million in Q3 2025.

Pluri (PLUR) Non-Current Assets (2011 - 2025) Analysis & Trends

Pluri (PLUR) has 15 years of Non-Current Assets data on file, last reported at $16.8 million in Q4 2025.

  • Non-Current Assets for Q4 2025 came in at $16.8 million, up 97.76% year-over-year; the trailing twelve-month figure through Dec 2025 was $16.8 million (up 97.76% YoY), and the FY2025 annual result was $16.6 million, up 97.01% from the prior year.
  • Non-Current Assets held at $16.8 million in Q4 2025 per PLUR's latest filing, from $16.8 million in the prior quarter.
  • Over five years, Non-Current Assets peaked at $29.4 million in Q1 2021 and troughed at $8.4 million in Q3 2024.
  • A 5-year average of $13.7 million and a median of $10.0 million in 2022 frame the typical range for Non-Current Assets.
  • The sharpest annual moves came in 2021 and 2022: Non-Current Assets surged 464.39% in 2021, then tumbled 60.57% in 2022.
  • A 5-year view of Non-Current Assets shows it stood at $21.0 million in 2021, then slumped by 53.46% to $9.8 million in 2022, then slipped by 4.85% to $9.3 million in 2023, then retreated by 8.82% to $8.5 million in 2024, then soared by 97.76% to $16.8 million in 2025.
  • Business Quant data shows PLUR's Non-Current Assets at $16.8 million in Q4 2025, $16.8 million in Q3 2025, and $16.6 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - 62,953.78
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - 289.41 Mn
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - 4.56 Mn
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 486.60 Mn
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - 30.30 Mn
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - 5.18 Mn
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 14.75 Bn
9 Abivax 94.37 Bn 94.37 Bn - 39.71 Mn
10 Pluri 21.39 Mn 21.87 Mn 86,000.00 16.79 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 16.79 Mn
Sep 30, 2025 16.75 Mn
Jun 30, 2025 16.59 Mn
Mar 31, 2025 9.95 Mn
Dec 31, 2024 8.49 Mn
Sep 30, 2024 8.41 Mn
Jun 30, 2024 8.42 Mn
Mar 31, 2024 9.02 Mn
Dec 31, 2023 9.31 Mn
Sep 30, 2023 9.28 Mn
Jun 30, 2023 9.39 Mn
Mar 31, 2023 9.55 Mn
Dec 31, 2022 9.79 Mn
Sep 30, 2022 10.03 Mn
Jun 30, 2022 10.32 Mn
Mar 31, 2022 14.81 Mn
Dec 31, 2021 21.03 Mn
Sep 30, 2021 20.92 Mn
Jun 30, 2021 26.17 Mn
Mar 31, 2021 29.35 Mn